Skip to main content

FDA Approvals

In the News, FDA Approvals
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Phoebe Starr
Read More
FDA Approvals
The Oncology Drug Pipeline Shows No Evidence of Slowing Down
Wayne Kuznar
Read More
FDA Approvals, In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
FDA Approvals, In the News
Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis
Read More
FDA Approvals
Innovation Tops Current Trends in the 2016 Oncology Drug Pipeline
Dalia Buffery, MA, ABD
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors
Read More
FDA Approvals
Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer
Lilly Ostrovsky
Read More
FDA Approvals, Payers' Guide
ProAir RespiClick (Albuterol Sulfate): First Breath-Actuated Inhaler Approved for the Treatment or Prevention of Bronchospasm
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Page 35 of 53
Results 341 - 350 of 528